In this webinar, Colin Edgerton, Executive Chairman of American Rheumatology Network and Mary Jo Carden, Head of Policy at Sandoz Inc. will discuss the clinical and policy issues surrounding the future success of biosimilars in the pharmacy benefit.


  • Colin Edgerton, MD
    Executive Chairman
    American Rheumatology Network
  • Mary Jo Carden, RPh, JD
    Head of Policy
    Sandoz Inc.
** IMPORTANT: AMCP webinars are limited to the first 1000 that join the webinar. However, AMCP will provide a link to the recording and slides to all registrants within a week from the webinar date. The recording and slides of sponsored webinars will be provided if permitted by the sponsor.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.